Bruker Corporation 

(Public, NASDAQ:BRKR)   Watch this stock   
Find more results for BRKR
Nov 17, 2009
Lazard Capital Healthcare Conference - Webcast
Oct 29, 2009
Q3 2009 Earnings Conference Call - Webcast
Oct 29, 2009
Q3 2009 Earnings Release
Sep 11, 2009
Thomas Weisel Partners Healthcare Conference - Webcast
More events from AOL Finance »    

Key stats and ratios

Q3 (Sep '09) 2008
Net profit margin 6.07% 5.89%
Operating margin 9.81% 9.77%
EBITD margin - 12.47%
Return on average assets 5.84% 5.37%
Return on average equity 18.58% 13.71%
Employees 3,850 -

Address

40 Manning Park
Billerica, MA 01821
United States - Map
+1-978-6633660 (Phone)
+1-978-6675993 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance
Annual Report (PDF) - AnnualReports.com

Bruker Corporation discussed on blogs

Ranking All U.S. Stocks by Weekly Performance - NASD100.com ... - Investor's Resources - NASD100.com - Daily Stock Rankings - 8 hours ago
Ranking 1500+ Small Cap Stocks by Year-to-Date Performance ... - Investor's Resources - NASD100.com - Daily Stock Rankings - Nov 20, 2009

Bruker Corporation discussions

  View all discussions »

Description

Bruker Corporation designs, manufactures, markets and services life science and materials research systems and associated products to address the needs of its customers in life science research and pharmaceutical, biotechnology and molecular diagnostics research, as well as in materials and chemical analysis in various industries and government applications. Its core technology platforms include X-ray technologies, magnetic resonance technologies, mass spectrometry technologies, optical emission spectroscopy and infrared and Raman molecular spectroscopy technologies. It also manufactures and distributes a range of field analytical systems for chemical, biological, radiological and nuclear (CBRN), detection, as well as superconducting wire products and devices. It operates in four divisions: Bruker AXS, Bruker Daltonics, Bruker Optics and Bruker BioSpin.

Officers and directors

Frank H. Laukien Ph.D.
Chairman of the Board, President, Chief Executive Officer
Age: 49
Bio & Compensation - Reuters
Brian P. Monahan
Chief Financial Officer
Age: 38
Bio & Compensation - Reuters
William J. Knight
Chief Operating Officer
Age: 60
Bio & Compensation - Reuters
Richard M. Stein
Secretary, Director
Age: 57
Bio & Compensation - Reuters
William A. Linton
Lead Director
Age: 61
Bio & Compensation - Reuters
Collin J. D'Silva
Director
Age: 52
Bio & Compensation - Reuters
Bernhard Wangler
Director
Age: 58
Bio & Compensation - Reuters
Richard D. Kniss
Director
Age: 68
Bio & Compensation - Reuters
Joerg C. Laukien
Director
Age: 55
Bio & Compensation - Reuters